Journal article
First Line Treatment of Newly Diagnosed Transplant Eligible Multiple Myeloma Recommendations From a Canadian Consensus Guideline Consortium
Abstract
The availability of effective therapies for multiple myeloma (MM) has sparked debate on the role of first line autologous stem cell transplantation (ASCT), particularly in standard-risk patients. However, treatment for individuals with high-risk disease continues to display suboptimal outcomes. With novel therapies used earlier, practice is changing rapidly in the field of MM. Presently, quadruplet induction therapy incorporating an anti-CD38 …
Authors
Khan S; Bergstrom DJ; Côté J; Kotb R; LeBlanc R; Louzada ML; Mian HS; Othman I; Colasurdo G; Visram A
Journal
Clinical Lymphoma Myeloma & Leukemia, Vol. 25, No. 3, pp. e151–e172
Publisher
Elsevier
Publication Date
3 2025
DOI
10.1016/j.clml.2024.10.012
ISSN
2152-2650